Kennedy Jonathan 4
4 · NATUS MEDICAL INC · Filed Jan 5, 2021
Insider Transaction Report
Form 4
Kennedy Jonathan
Sr. VP, CFO
Transactions
- Other
Common Stock, $0.001 par value per share
2020-12-31$20.04/sh−22,695$454,808→ 139,590 total - Award
Common Stock, $0.001 par value per share
2021-01-04$20.61/sh+66,716$1,375,017→ 191,321 total - Award
Non-qualified Stock Option
2021-01-04+66,716→ 66,716 totalExercise: $20.61From: 2022-01-04Exp: 2031-01-04→ Common Stock (66,716 underlying) - Tax Payment
Common Stock, $0.001 par value per share
2021-01-02$20.04/sh−14,985$300,299→ 124,605 total
Footnotes (3)
- [F1]Performance Restricted Stock cancelled previously reported on the August 2018 Form 4 due to performance goals not met.
- [F2]Restricted Stock Awards vest 25% on the anniversary of the grant over 4 years. Includes a total of 16,679 shares deferred pursuant to the terms of the deferred stock grant under Natus' Non-Qualified Deferred Compensation Plan.
- [F3]Stock Options vest 25% on the anniversary of the grant over 4 years.